← peptides typeshit

Retatrutide's TRIUMPH-1 trial shows 28.3% average weight loss at 80 weeks

Medscape reports the top studied dose reached weight loss levels typically linked to bariatric surgery in Lilly's pivotal trial.

See it on X

Recap by typeshit. Post by Medscape on X.